top of page
Helix Web Overlay 2.jpg

Who's at Helix? | Che Connon on building world-leading biotech from Newcastle

rebeccacartwright42
10 minutes ago
3 min read

Growing tissue without animals. Creating sustainable alternatives to leather. Developing technologies that could help tackle corneal blindness.


Although these challenges might seem worlds apart, they're all examples of breakthrough science leaving the laboratory and finding real-world applications. That's exactly what Che Connon and BSF Enterprise PLC are doing from their base at Newcastle Helix.


As CEO of BSF Enterprise PLC, Che leads a group of biotechnology businesses built on years of tissue engineering research. From regenerative medicine and life sciences to sustainable luxury materials, the organisation is turning scientific discovery into products with global reach.


Based at The Biosphere on Newcastle Helix, the business is demonstrating that world-class biotechnology can be developed, commercialised and scaled from the North East.


From academic research to commercial impact


Before leading a publicly listed biotechnology company, Che spent more than a decade as a Professor of Tissue Engineering at Newcastle University. His research focused on understanding how cells and tissues can be grown and engineered, but over time he shifted his focus towards a new challenge.


How could those discoveries be transformed into products and technologies that could make a real difference beyond academia?


That ambition became the foundation for BSF Enterprise PLC, bringing together businesses built around a common expertise in tissue engineering and biotechnology.


Today those include:

  • 3D Bio-Tissues, which supplies materials and consumables that support the cultivation of cells and tissues.

  • Lab-Grown Leather, which is developing sustainable alternatives to traditional animal-derived leather.

  • Kerato, a corneal tissue engineering company focused on tackling one of healthcare's most significant unmet needs.



The project that captured global attention


Earlier this year, one of the group's innovations generated headlines around the world.

Through Lab-Grown Leather, the team unveiled the world's first handbag created using cultivated T-Rex Leather™, a project that combined biotechnology, sustainability and creativity in a way that captured global attention.


Created in collaboration with VML Paris, the campaign went on to win four major awards at the Cannes Lions International Festival of Creativity 2026, placing Newcastle-developed innovation on one of the world's biggest stages.


While the concept attracted headlines, Che sees the project as proof of something much bigger.


It demonstrated that technologies developed for tissue engineering can have applications far beyond healthcare and research, opening entirely new commercial opportunities while reducing reliance on traditional animal-based materials.


Beyond leather


While cultivated leather may have captured imaginations, healthcare remains a major focus.


Through subsidiary Kerato, the business is developing a liquid cornea technology designed to help address the global shortage of donor corneas. With more than 13 million people worldwide waiting for corneal transplants, the technology has the potential to improve access to treatment while reducing reliance on donor tissue.


The business is also working on technologies involving peptides and biomaterials, exploring opportunities across healthcare, cosmetics and advanced biotechnology applications.


The company's work across healthcare, sustainable materials and life sciences highlights the versatility of the platform underpinning the business. The same scientific expertise can create opportunities across multiple industries, from consumer products and luxury materials to life-changing medical innovations.


Building global businesses from Newcastle


As the company grows, so does its international reach. From attracting investment to selling products internationally, BSF Enterprise is demonstrating how Newcastle-developed innovation can compete on a global stage.


Yet despite that global reach, Che remains passionate about the region where the business was founded.


For decades, ambitious technology businesses often felt pressure to relocate to London, Cambridge or Silicon Valley in order to scale.


Che believes the North East tells a different story.

"We're showing that that's not the case. You can generate high value jobs within a high tech company setup here in the northeast, here in the Helix, bringing in international investment, selling products internationally. It's all possible."

Supported by the region's universities, talent base and growing innovation ecosystem, businesses like BSF Enterprise are demonstrating that globally significant innovation can be created and commercialised from Newcastle.


Looking ahead


For a company working across sectors as varied as regenerative medicine, fashion, materials science and biotechnology, the opportunities ahead are significant.

Yet when Che reflects on the journey so far, it is the team behind the innovation that stands out.

"When I do find a brief moment to step back and look, I'm really, really impressed with the progress that the team has made."

From award-winning campaigns and international partnerships to healthcare technologies with the potential to change lives, BSF Enterprise is showing what happens when scientific excellence meets commercial ambition.


And as the business continues to grow from its home at The Biosphere, Newcastle Helix, it is providing further evidence that world-leading innovation is not something the North East simply supports.


It's something the region is creating.


🎥 Watch our conversation with Che in his own words

 
 
bottom of page